On the basis of its upregulation, FANCD2 may contribute to tumorigenesis and impart an unfavorable prognosis to various types of cancers, including esophageal squamous cell carcinoma, head and neck cancer, nasopharyngeal carcinoma, and lung adenocarcinoma [62,63,64,65]. This evidence concerns the gene FANCD2 and lung adenocarcinoma.